Showing 2461-2470 of 7028 results for "".
Physician Spotlight: Valerie Harvey, MD, MPH, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-valerie-harvey-md-mph-faad/23595/Using Technology to Detect Skin Cancer, Profile Lesions, and Streamline Your Practice
https://practicaldermatology.com/topics/practice-management/using-technology-to-detect-skin-cancer-profile-lesions-and-streamline-your-practice/23572/Technology solutions may help dermatologists turn the tide on the skin cancer epidemic.What Every Dermatologist Should Know About AI
https://practicaldermatology.com/topics/practice-management/what-every-dermatologist-should-know-about-ai/23569/As augmented intelligence evolves, here are seven things every dermatologist should know about its potential and its limitations.Safe and Careful
https://practicaldermatology.com/series/editors-message/safe-and-careful/23563/Cosmetic Surgery Forum 2021 will open to vaccinated attendees and exhibitors.New in My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-3/23492/New Products/New in My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-8/23455/Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.New Products
https://practicaldermatology.com/columns/new-products/new-products-2/23356/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-16/23328/DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-19-loans-taltz-for-peds-finacea-returns/19808/SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients a